JP2022526014A5 - - Google Patents
Info
- Publication number
- JP2022526014A5 JP2022526014A5 JP2021559817A JP2021559817A JP2022526014A5 JP 2022526014 A5 JP2022526014 A5 JP 2022526014A5 JP 2021559817 A JP2021559817 A JP 2021559817A JP 2021559817 A JP2021559817 A JP 2021559817A JP 2022526014 A5 JP2022526014 A5 JP 2022526014A5
- Authority
- JP
- Japan
- Prior art keywords
- appears
- following structure
- independently
- bond
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024216317A JP7903604B2 (ja) | 2019-04-11 | 2024-12-11 | プログラム可能なポリマー薬 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962832723P | 2019-04-11 | 2019-04-11 | |
| US62/832,723 | 2019-04-11 | ||
| US201962877144P | 2019-07-22 | 2019-07-22 | |
| US62/877,144 | 2019-07-22 | ||
| PCT/US2020/027750 WO2020210689A1 (en) | 2019-04-11 | 2020-04-10 | Programmable polymeric drugs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024216317A Division JP7903604B2 (ja) | 2019-04-11 | 2024-12-11 | プログラム可能なポリマー薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526014A JP2022526014A (ja) | 2022-05-20 |
| JP2022526014A5 true JP2022526014A5 (enExample) | 2024-07-11 |
| JP7603918B2 JP7603918B2 (ja) | 2024-12-23 |
Family
ID=70476549
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559817A Active JP7603918B2 (ja) | 2019-04-11 | 2020-04-10 | プログラム可能なポリマー薬 |
| JP2024216317A Active JP7903604B2 (ja) | 2019-04-11 | 2024-12-11 | プログラム可能なポリマー薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024216317A Active JP7903604B2 (ja) | 2019-04-11 | 2024-12-11 | プログラム可能なポリマー薬 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220160887A1 (enExample) |
| EP (1) | EP3952916A1 (enExample) |
| JP (2) | JP7603918B2 (enExample) |
| KR (1) | KR20210152523A (enExample) |
| CN (1) | CN114430738A (enExample) |
| WO (1) | WO2020210689A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| WO2016138461A1 (en) | 2015-02-26 | 2016-09-01 | Sony Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| KR102646956B1 (ko) | 2015-02-26 | 2024-03-14 | 소니그룹주식회사 | 페닐에티닐나프탈렌 염료 및 이의 사용 방법 |
| KR102765335B1 (ko) | 2015-05-11 | 2025-02-13 | 소니그룹주식회사 | 초휘도 이량체성 또는 중합체성 염료 |
| EP3436528B1 (en) | 2016-04-01 | 2025-07-02 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes with rigid spacing groups |
| BR112018070164B1 (pt) | 2016-04-01 | 2022-09-27 | Sony Corporation Of America | Corantes diméricos ou poliméricos ultrabrilhantes |
| CN109153860B (zh) | 2016-04-06 | 2021-04-23 | 索尼公司 | 具有间隔连接体基团的超高亮二聚体或聚合物染料 |
| WO2017189805A1 (en) | 2016-04-27 | 2017-11-02 | Abbvie Inc. | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| BR112018073199A2 (pt) | 2016-05-11 | 2019-04-16 | Sony Corporation | corantes diméricos ou poliméricos ultrabrilhantes |
| WO2018022925A1 (en) | 2016-07-29 | 2018-02-01 | Sony Corporation | Ultra bright dimeric or polymeric dyes and methods for preparation of the same |
| KR20260011205A (ko) | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| CN111836645A (zh) | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| WO2019140128A1 (en) | 2018-01-12 | 2019-07-18 | Sony Corporation | Phosphoalkyl polymers comprising biologically active compounds |
| EP3737417B1 (en) | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| US12076407B2 (en) | 2018-01-12 | 2024-09-03 | Sony Group Corporation | Polymers with rigid spacing groups comprising biologically active compounds |
| EP3769085B1 (en) | 2018-03-19 | 2022-08-24 | Sony Group Corporation | Use of divalent metals for enhancement of fluorescent signals |
| KR102864292B1 (ko) | 2018-03-21 | 2025-09-26 | 소니그룹주식회사 | 링커 군을 갖는 중합체성 텐덤 염료 |
| JP7580689B2 (ja) | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| US12578342B2 (en) | 2018-07-13 | 2026-03-17 | Sony Group Corporation | Polymeric dyes having a backbone comprising organophosphate units |
| EP3861074A2 (en) | 2019-09-26 | 2021-08-11 | Sony Group Corporation | Polymeric tandem dyes with linker groups |
| EP4038081A1 (en) | 2019-09-30 | 2022-08-10 | Sony Group Corporation | Nucleotide probes |
| KR20230092863A (ko) | 2020-06-11 | 2023-06-26 | 프로벤션 바이오, 인코포레이티드 | 제1형 당뇨병을 예방하기 위한 방법 및 조성물 |
| EP4256078A1 (en) | 2020-12-07 | 2023-10-11 | Sony Group Corporation | Spacing linker group design for brightness enhancement in dimeric or polymeric dyes |
| MX2023013851A (es) | 2021-05-24 | 2023-12-08 | Provention Bio Inc | Metodos para el tratamiento de diabetes tipo 1. |
| US20240350645A1 (en) * | 2021-07-22 | 2024-10-24 | Sony Group Corporation | Automated synthesis of polymeric drugs |
| CN117750977A (zh) * | 2021-07-22 | 2024-03-22 | 索尼集团公司 | 聚合型药物的自动合成 |
| EP4590340A1 (en) * | 2022-09-22 | 2025-07-30 | Sony Group Corporation | Polymers with steroids or vitamins |
| CN120077057A (zh) | 2022-10-04 | 2025-05-30 | 伊莱利利公司 | Trem2相关疾病和病症的基因治疗 |
| AR131035A1 (es) | 2022-11-11 | 2025-02-12 | Lilly Co Eli | Ácidos nucleicos sintéticos que incluyen constructos promotores dirigidos a astrocitos y métodos de uso de los mismos |
| WO2026043765A1 (en) | 2024-08-21 | 2026-02-26 | Eli Lilly And Company | Engineered regulatory splice elements for gene therapies |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9545447B2 (en) * | 2013-01-04 | 2017-01-17 | The Texas A&M University System | Polymer-drug systems |
| EP3019559A4 (en) * | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| WO2016138461A1 (en) | 2015-02-26 | 2016-09-01 | Sony Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| KR102765335B1 (ko) * | 2015-05-11 | 2025-02-13 | 소니그룹주식회사 | 초휘도 이량체성 또는 중합체성 염료 |
| JP6817288B2 (ja) * | 2015-08-10 | 2021-01-20 | ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． | 新規な連結体及び生体分子と薬物との特異的共役におけるその使用 |
| EP3436528B1 (en) * | 2016-04-01 | 2025-07-02 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes with rigid spacing groups |
| BR112018070164B1 (pt) * | 2016-04-01 | 2022-09-27 | Sony Corporation Of America | Corantes diméricos ou poliméricos ultrabrilhantes |
| CN109153860B (zh) * | 2016-04-06 | 2021-04-23 | 索尼公司 | 具有间隔连接体基团的超高亮二聚体或聚合物染料 |
| US11390754B2 (en) * | 2016-05-10 | 2022-07-19 | Sony Corporation | Compositions comprising a polymeric dye and a cyclodextrin and uses thereof |
| BR112018073199A2 (pt) * | 2016-05-11 | 2019-04-16 | Sony Corporation | corantes diméricos ou poliméricos ultrabrilhantes |
| WO2018022925A1 (en) * | 2016-07-29 | 2018-02-01 | Sony Corporation | Ultra bright dimeric or polymeric dyes and methods for preparation of the same |
| KR20260011205A (ko) * | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| US12290571B2 (en) * | 2017-10-05 | 2025-05-06 | Sony Group Corporation | Programmable dendritic drugs |
| CN111836645A (zh) * | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| EP3737417B1 (en) * | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| US12076407B2 (en) * | 2018-01-12 | 2024-09-03 | Sony Group Corporation | Polymers with rigid spacing groups comprising biologically active compounds |
| EP3769085B1 (en) * | 2018-03-19 | 2022-08-24 | Sony Group Corporation | Use of divalent metals for enhancement of fluorescent signals |
| KR102864292B1 (ko) * | 2018-03-21 | 2025-09-26 | 소니그룹주식회사 | 링커 군을 갖는 중합체성 텐덤 염료 |
| JP7580689B2 (ja) * | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| EP3861074A2 (en) * | 2019-09-26 | 2021-08-11 | Sony Group Corporation | Polymeric tandem dyes with linker groups |
-
2020
- 2020-04-10 EP EP20722939.4A patent/EP3952916A1/en active Pending
- 2020-04-10 US US17/602,689 patent/US20220160887A1/en active Pending
- 2020-04-10 CN CN202080040293.XA patent/CN114430738A/zh active Pending
- 2020-04-10 KR KR1020217036843A patent/KR20210152523A/ko not_active Ceased
- 2020-04-10 WO PCT/US2020/027750 patent/WO2020210689A1/en not_active Ceased
- 2020-04-10 JP JP2021559817A patent/JP7603918B2/ja active Active
-
2024
- 2024-12-11 JP JP2024216317A patent/JP7903604B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526651A5 (enExample) | ||
| JP2022526017A5 (enExample) | ||
| US20200247887A1 (en) | Anti-cd79b antibodies and immunoconjugates and methods of use | |
| JP2024536224A5 (enExample) | ||
| JP2024537069A5 (enExample) | ||
| CN102580084B (zh) | Her抗体的固定剂量给药 | |
| EP3952917A1 (en) | Programmable polymeric drugs | |
| EP3952916A1 (en) | Programmable polymeric drugs | |
| CN120037399A (zh) | 可编程的聚合药物 | |
| US7378091B2 (en) | Antibodies against carbonic anhydrase IX (CA IX) tumor antigen | |
| EP2424567B1 (en) | Method for making heteromultimeric molecules | |
| IL287292B (en) | and fusion antibody-drug-cd79b engineered antibodies cysteine- | |
| JP2008523073A (ja) | Ｈｅｒ阻害剤を用いた治療のための患者の選択 | |
| US20250009786A1 (en) | Automated synthesis of polymeric dual drugs | |
| EP4408477A1 (en) | Pyrrolobenzodiazepine conjugates for cancer treatment | |
| US20240307548A1 (en) | Enhanced targeting using antibody-oligonucleotide conjugates | |
| JP2024532726A5 (enExample) | ||
| EP4285936A1 (en) | Antibody-drug conjugate and medical use thereof | |
| TW202003044A (zh) | 可釋放之抗體結合物 | |
| JP2023549925A5 (enExample) | ||
| EP4622675A1 (en) | Polymeric compounds comprising antineoplastic agents | |
| KR20250079213A (ko) | 화합물, 조성물 및 방법 | |
| TWI534148B (zh) | 吡唑並嘧啶前藥及其使用方法 | |
| TW202517255A (zh) | 化合物、組合物及方法 | |
| TW202504641A (zh) | 用於淋巴瘤之診斷及治療方法的巨噬細胞特徵 |